When more target antigen expression is less
Cancer Cell · 2026-06 · 44 (6) · 1119-1120
DOI: 10.1016/j.ccell.2026.05.003 ↗Kurz gefasst
Kommentar in der Zeitschrift Cancer Cell, 2026-06. Verfasst von Charles Dumontet. Beteiligte Einrichtung: Université Claude Bernard Lyon 1, INSERM U-1052, CNRS 5286, Centre Léon Bérard, Hospices Civils de Lyon, Centre de Recherche en Cancérologie de Lyon,…. Hauptthemen laut MEDLINE: Cell Adhesion Molecules, Immunoconjugates, Drug Resistance, Neoplasm, Neoplasms. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Resistance to antibody drug conjugates (ADCs) may be due to low target antigen expression resulting in reduced intracellular payload concentration. In this issue of Cancer Cell, Wang et al. show that increased target antigen NECTIN4 expression is associated with reduced NECTIN4-ADC internalization and enhanced extracellular ADC release in a resistant tumor cell subpopulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Université Claude Bernard Lyon 1, INSERM U-1052, CNRS 5286, Centre Léon Bérard, Hospices Civils de Lyon, Centre de Recherche en Cancérologie de Lyon, 69008 Lyon, France. Electronic address: charles.dumontet@chu-lyon.fr.
Zitieren
APA
Dumontet, C. (2026). When more target antigen expression is less. Cancer Cell, 44(6), 1119-1120. https://doi.org/10.1016/j.ccell.2026.05.003
Vancouver
Dumontet C. When more target antigen expression is less. Cancer Cell. 2026;44(6):1119-1120. doi:10.1016/j.ccell.2026.05.003
BibTeX
@article{Dumontet2026,
author = {Dumontet, Charles},
title = {When more target antigen expression is less},
journal = {Cancer Cell},
year = {2026},
volume = {44},
number = {6},
pages = {1119--1120},
doi = {10.1016/j.ccell.2026.05.003}
}
EUVIMED